We recorded the percentage and intensity of antigen expression of CLL makers, including CD5, CD20, CD23, CD79b, CD200 and sIgM, and assessed whether these affected the adapted and modified Matutes scores. This evidence concerns the gene MS4A1 and B-cell chronic lymphocytic leukemia.